These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35950392)
1. [Treatment and prognosis of multiple primary malignant neoplasms complicated with renal cell carcinoma]. Qiu M; Lian YY; Lu M; Wang BS; Tian XJ; Lu J; Liu C; Zhang SD; Jiang M; Ma LL Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):680-685. PubMed ID: 35950392 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic Features and Prognosis of Sporadic Bilateral Renal Cell Carcinoma: A Series of 148 Cases. Qi N; Li T; Ning X; Peng X; Cai L; Gong K Clin Genitourin Cancer; 2017 Oct; 15(5):618-624. PubMed ID: 28648756 [TBL] [Abstract][Full Text] [Related]
4. [Gynecological malignant tumor related multiple primary malignant neoplasms: clinical analysis of 30 cases]. Shi L; Zhou S; Jiang Y; Wan Y; Ma J; Fu S; Cheng W Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):199-203. PubMed ID: 24820305 [TBL] [Abstract][Full Text] [Related]
5. Concurrent renal cell carcinoma and urothelial carcinoma: long-term follow-up study of 27 cases. Qi N; Chen Y; Gong K; Li H World J Surg Oncol; 2018 Jan; 16(1):16. PubMed ID: 29370814 [TBL] [Abstract][Full Text] [Related]
6. High incidence combination of multiple primary malignant tumors of the digestive system. Yang XB; Zhang LH; Xue JN; Wang YC; Yang X; Zhang N; Liu D; Wang YY; Xun ZY; Li YR; Sun HS; Zhao LJ; Zhao HT World J Gastroenterol; 2022 Nov; 28(41):5982-5992. PubMed ID: 36405110 [TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors]. He Y; Wang Y; Ji C; Liu Y; Wu YM Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326 [No Abstract] [Full Text] [Related]
8. Multiple primary malignant neoplasms: multi-center results from Turkey. Babacan NA; Aksoy S; Cetin B; Ozdemir NY; Benekli M; Uyeturk U; Ali Kaplan M; Kos T; Karaca H; Oksuzoglu B; Zengin N; Buyukberber S J BUON; 2012; 17(4):770-5. PubMed ID: 23335539 [TBL] [Abstract][Full Text] [Related]
10. A 12-year experience at a tertiary hospital on patients with multiple primary malignant neoplasms. Papaconstantinou I; Mantzos DS; Asimakoula K; Michalaki V; Kondi-Pafiti A J BUON; 2015; 20(1):332-7. PubMed ID: 25778335 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology, Pattern, and Survival of Multiple Primary Malignant Neoplasms in Southeast Iran: Results of Kerman Population-Based Cancer Registry 2014-2020. Malekpour Afshar R; Mousavi B; Bazrafshani MS; Movahedinia S; Zohreh-Kermani A; Nejad Ravari M; Mirzaie H; Shahesmaeili A; Bazrafshan A Asian Pac J Cancer Prev; 2024 Jul; 25(7):2257-2264. PubMed ID: 39068556 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and prognostic analysis of multiple primary malignant neoplasms in patients with lung cancer. Wang H; Hou J; Zhang G; Zhang M; Li P; Yan X; Ma Z Cancer Gene Ther; 2019 Nov; 26(11-12):419-426. PubMed ID: 30700800 [TBL] [Abstract][Full Text] [Related]
13. Sorafenib combined with radiofrequency ablation in the treatment of a patient with renal cell carcinoma plus primary hepatocellular carcinoma. Gang G; Hongkai Y; Xu Z J Cancer Res Ther; 2015; 11(4):1026. PubMed ID: 26881596 [TBL] [Abstract][Full Text] [Related]
14. Contralateral metachronous tumor occurrence is more frequently associated with distant metastases or postoperative intrarenal recurrence in renal cell carcinoma patients. Amano H; Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Shimada K; Nakazawa H; Ito F; Tanabe K Int J Urol; 2010 Jul; 17(7):615-22. PubMed ID: 20482658 [TBL] [Abstract][Full Text] [Related]
15. [Survival analysis of surgically treated renal cell carcinoma: an analysis of 10-year data from single center]. Zhang YS; Yu HY; Dong F; Li HZ Zhonghua Wai Ke Za Zhi; 2016 Jul; 54(7):528-33. PubMed ID: 27373480 [TBL] [Abstract][Full Text] [Related]
16. Multiple primary tumors: 17 cases of renal-cell carcinoma associated with primary tumors involving different steroid-hormone target tissues. Di Silverio F; Sciarra A; Flammia GP; Mariani M; De Vico A World J Urol; 1997; 15(3):203-9. PubMed ID: 9228728 [TBL] [Abstract][Full Text] [Related]
17. Multiple primary malignant neoplasms: A 10-year experience at a single institution from Turkey. Etiz D; Metcalfe E; Akcay M J Cancer Res Ther; 2017; 13(1):16-20. PubMed ID: 28508827 [TBL] [Abstract][Full Text] [Related]
18. Italian cancer figures--Report 2015: The burden of rare cancers in Italy. ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748 [TBL] [Abstract][Full Text] [Related]
19. Identification and validation of novel prognostic markers in Renal Cell Carcinoma. Rabjerg M Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890 [TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological characteristics of multiple primary malignant neoplasms cases. Si L; Feng Y; Wang Y; Zhong J; Sun Z; Li X; Sun Y Int J Clin Pract; 2021 Nov; 75(11):e14663. PubMed ID: 34387916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]